Skip to main content

Table 2 Comparing groups of patients with or without pulmonary HTN regarding demographic data and ESS (n = 100)

From: Correlation between serum uric acid and pulmonary arterial hypertension based on echo probability in patients with obstructive sleep apnea syndrome

 

Total (n = 100)

Pulmonary HTN

Test of sig

p

No (n = 22)

Yes (n = 78)

No

%

No

%

No

%

Sex

 Male

66

66.0

16

72.7

50

64.1

χ2 = 0.569

0.451

 Female

34

34.0

6

27.3

28

35.9

Age (years)

 Min.–max

33.0–70.0

33.0–60.0

36.0–70.0

t = 2.489*

0.015*

 Mean ± SD

53.04 ± 8.45

49.18 ± 8.63

54.13 ± 8.12

 Median (IQR)

53.0 (49.0–58.0)

53.0 (42.0–55.0)

53.0 (49.0–60.0)

BMI

 Overweight

6

6.0

6

27.3

0

0.0

χ2 = 17.654*

MCp < 0.001*

 Obese

90

90.0

16

72.7

74

94.9

 Morbid obese

4

4.0

0

0.0

4

5.1

 Min.–max

25.50–40.96

25.50–36.70

30.44–40.96

t = 7.350*

 < 0.001*

 Mean ± SD

34.69 ± 3.10

31.23 ± 3.07

35.66 ± 2.32

 Median (IQR)

35.4 (32.4–36.8)

31.20 (29.0–32.40)

35.99 (34.2–37.1)

ESS

 Normal (≤ 10)

6

6.0

2

9.1

4

5.1

χ2 = 0.478

FEp = 0.610

 Abnormal (> 10)

94

94.0

20

90.9

74

94.9

Min.–max

10.0–20.0

10.0–20.0

10.0–20.0

t = 2.241*

0.027*

Mean ± SD

13.90 ± 2.62

12.82 ± 2.79

14.21 ± 2.50

Median (IQR)

14.0 (12.0–16.0)

12.0 (11.0–13.0)

14.0 (12.0–16.0)

  1. *means significant